E2F1 and glioblastoma: We observed that JAS239 significantly reduces the protein expression of E2F1 in four GBM cell lines, with the most notable reduction in F98 cells (data not shown), potentially explaining this observation of JAS239‐induced reductions in mI/Cr levels.